fashion -WSS

fashion

author：Wikipedia 2025-08-11 08:01:10 - browse：495

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Pushing for an NIH office for post

WSS

Change Healthcare outage fallout shows need for new oversight

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

President Biden's budget: Here's what you might have missed

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

UCLA team creates talking throat patch for voice disorders

How to save health care price transparency rules

leisure time

fashion

focus

Affirmative action in medical school literally saved lives

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

New air purifier tech could be key to improving indoor air quality

Tuberculosis patients need more than just free medication

In age of alternative facts, a scholarly course on calling out crap

NFL doctors' conflicts of interest could endanger players, report says

Medicare proposal to cover medical devices draws a mixed reaction

Sweden knocks USA out of World Cup in penalty kicks

In age of alternative facts, a scholarly course on calling out crap

John Green on his newest strategy for fighting tuberculosis

explore

As AI in medicine takes off, can 'human in the loop' prevent harm?

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Kansas bar where gunfire wounded 9 last month closes permanently

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

'Brian's Song' at 50 still offers lessons about cancer for today

Pushing for an NIH office for post

hotspot

knowledge

Wikipedia

focus